Efficacy of Non-Nutritive Sucking (NNS) on Balance and Gait Measured in 12-42 Month-Old Healthy Children Over 36 Months
Launched by BAMBINO GESÙ HOSPITAL AND RESEARCH INSTITUTE · Jan 9, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether non-nutritive sucking (NNS), like sucking on a pacifier or thumb, can help improve balance and walking skills in healthy children aged 12 to 42 months. The research aims to provide clearer information about the benefits and possible risks of NNS, as there has been a lot of confusion and differing opinions on when children should stop these habits. Parents often feel pressured to have their children give up sucking, despite its potential benefits, such as reducing crying and helping with sleep.
To be eligible for the trial, children must be healthy and between 12 and 42 months old, and they should have a history of prolonged NNS. However, children with certain medical conditions, like specific facial abnormalities or swallowing difficulties, cannot participate. Families who join the study can expect to be followed for three years to see how NNS affects their child's balance and walking. This study is actively recruiting participants, so it's a great opportunity for families interested in contributing to important research on this topic.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • • Healthy boys and girls ranging in age from 12 to 42 months who tended to prolong NNS.
- • Exclusion criteria
- • Children with craniofacial malformations or with a known or clinically suspected genetic syndrome (for example Down syndrome);
- • Children with atypical swallowing for example tongue interposition, or dysphagia during swallowing caused by tongue interposition;
- • Children who already have mixed dentition.
About Bambino Gesù Hospital And Research Institute
Bambino Gesù Hospital and Research Institute, located in Rome, Italy, is a leading pediatric healthcare facility renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institute focuses on developing cutting-edge therapies and interventions for various pediatric conditions, underpinned by a multidisciplinary approach that integrates clinical practice, research, and education. With a strong emphasis on patient-centered care, Bambino Gesù fosters collaboration with international research networks and regulatory bodies to ensure the highest standards of safety and efficacy in its trials, ultimately striving to improve health outcomes for children globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Roma, , Italy
Patients applied
Trial Officials
Paola ROSATI, MD MSc
Principal Investigator
Bambino Gesù Children's Hospital IRCCS Rome
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials